The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previou...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2024-06-01
|
| Colección: | Stem Cell Research & Therapy |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13287-024-03778-1 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
